# The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy

Study · id `cardio:ct-nct03627130` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03627130](<https://clinicaltrials.gov/study/NCT03627130>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03627130

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 640 participants.

## Technical summary

Registry record NCT03627130. Randomized; quadruple masking; primary purpose treatment. Start 2018-11-29 (actual); primary completion 2022-05-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 640 participants (enrolled count; ClinicalTrials.gov record NCT03627130, source copy `cardio:ctgov-nct03627130-2022-12-16`, retrieved 2026-10-31)
- Started: 2018-11-29 (actual) (ClinicalTrials.gov record NCT03627130, source copy `cardio:ctgov-nct03627130-2022-12-16`, retrieved 2026-10-31)
- Primary completion: 2022-05-30 (actual) (ClinicalTrials.gov record NCT03627130, source copy `cardio:ctgov-nct03627130-2022-12-16`, retrieved 2026-10-31)
- Completion: 2022-05-30 (actual) (ClinicalTrials.gov record NCT03627130, source copy `cardio:ctgov-nct03627130-2022-12-16`, retrieved 2026-10-31)
- Countries: United Kingdom (ClinicalTrials.gov record NCT03627130, source copy `cardio:ctgov-nct03627130-2022-12-16`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03627130-2022-12-16`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
- Acronym: NITRATE-CIN
- Condition: Contrast-induced Nephropathy
- Condition: Acute Kidney Injury
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Potassium Nitrate
- Intervention (Drug): Potassium Chloride
- Lead sponsor: Barts & The London NHS Trust
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Barts & The London NHS Trust (`cardio:org-barts-the-london-nhs-trust`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial (`cardio:pubmed-38513060`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e9740dd4e178965dbc50ee9064124de01c676f6adae06a7bb104390945ee7632
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
